TABLE OF CONTENTS
|
 |  |  |
Volume 90, Issue 2 (August 2011) |
 | In this issue
In This Issue Editorial News & Views Perspectives Clinical Trial State of the Art Research Discovery & Development Regulation & Use Corrigenda Also new
   AOP
| | Advertisement |  Expand the automation boundaries. Agilent Technologies is celebrating the creativity of automation visionaries with the REACH BEYOND THE EXPECTED automation challenge. Tell the world your most creative automation idea - something you've done or something you'd like to do. Take part in the Agilent automation contest now and you could win a robot. Click here for all details. |
|
|
 |
 |
 |
| Advertisement |
 |
|
 |
| |
In This Issue | Top |
 |
IN THIS ISSUE
|
In This Issue Clin Pharmacol Ther 2011 90: 191; 10.1038/clpt.2011.158 Abstract | Full Text |
 |
Editorial | Top |
 |
EDITORIAL
|
Transplantation Pharmacology: Putting the Puzzle Together K S Reynolds Clin Pharmacol Ther 2011 90: 193-196; 10.1038/clpt.2011.143 Abstract | Full Text |
 |
News & Views | Top |
 |
HIGHLIGHTS
|
Highlights Clin Pharmacol Ther 2011 90: 198-199; 10.1038/clpt.2011.157 Abstract | Full Text |
 |
 |
 |
ASCPT NEWS
|
ASCPT News Clin Pharmacol Ther 2011 90: 200-202; 10.1038/clpt.2011.145 Abstract | Full Text |
 |
Perspectives | Top |
 |
POINT/COUNTERPOINT
|
Therapeutic Drug Monitoring for Mycophenolic Acid Is Value for (Little) Money T van Gelder Clin Pharmacol Ther 2011 90: 203-204; 10.1038/clpt.2011.96 Abstract | Full Text |
 |
 |
 |
Mycophenolate Mofetil Monitoring: Is There Evidence That It Can Improve Outcomes?R Byrne, S E Yost and B Kaplan Clin Pharmacol Ther 2011 90: 204-206; 10.1038/clpt.2011.95 Abstract | Full Text |
 |
 |
 |
Chronic Calcineurin Inhibitor Use Is NephrotoxicJ R Chapman Clin Pharmacol Ther 2011 90: 207-209; 10.1038/clpt.2011.117 Abstract | Full Text |
 |
 |
 |
Calcineurin Inhibitors: Short-Term Friend, Long-Term Foe?A J Matas Clin Pharmacol Ther 2011 90: 209-211; 10.1038/clpt.2011.77 Abstract | Full Text |
 |
 |
 |
OPINION
|
Ethical Considerations Regarding Disparities Pertaining to Kidney Transplant Patients S E Yost, T Srinivas and B Kaplan Clin Pharmacol Ther 2011 90: 212-214; 10.1038/clpt.2011.73 Abstract | Full Text |
 |
 |
 |
COMMENTARIES
|
A Perhaps Unexpected Role of Norepinephrine in Actions of MDMA T F Newton Clin Pharmacol Ther 2011 90: 215-216; 10.1038/clpt.2011.125 Abstract | Full Text |
 |
 |
 |
CONFERENCE PROCEEDINGS
|
Biomarkers in Solid-Organ Transplantation G Gieser, H Harigaya, P M Colangelo and G Burckart Clin Pharmacol Ther 2011 90: 217-220; 10.1038/clpt.2011.75 Abstract | Full Text |
 |
Clinical Trial | Top |
 |
CLINICAL TRIAL
|
A Phase I Study Evaluating Tolerability, Pharmacokinetics, and Preliminary Efficacy of L-Menthol in Upper Gastrointestinal Endoscopy N Hiki, M Kaminishi, T Hasunuma, M Nakamura, S Nomura, N Yahagi, H Tajiri and H Suzuki Clin Pharmacol Ther 2011 90: 221-228; advance online publication, May 4, 2011; 10.1038/clpt.2011.110 Abstract | Full Text |
 |
State of the Art | Top |
 |
STATE OF THE ART
|
Immunobiology of Transplantation: Impact on Targets for Large and Small Molecules A M Azimzadeh, J R Lees, Y Ding and J S Bromberg Clin Pharmacol Ther 2011 90: 229-242; advance online publication, June 29, 2011; 10.1038/clpt.2011.106 Abstract | Full Text |
 |
Research | Top |
 |
REPORTS
|
Prediction of Torsade de Pointes From the QT Interval: Analysis of a Case Series of Amisulpride Overdoses J P Joy, C V Coulter, S B Duffull and G K Isbister Clin Pharmacol Ther 2011 90: 243-245; advance online publication, June 29, 2011; 10.1038/clpt.2011.107 Abstract | Full Text |
 |
 |
 |
ARTICLES
|
The Norepinephrine Transporter Inhibitor Reboxetine Reduces Stimulant Effects of MDMA ("Ecstasy") in Humans C M Hysek, L D Simmler, M Ineichen, E Grouzmann, M C Hoener, R Brenneisen, J Huwyler and M E Liechti Clin Pharmacol Ther 2011 90: 246-255; advance online publication, June 15, 2011; 10.1038/clpt.2011.78 Abstract | Full Text |
 |
 |
 |
Pharmacokinetics and Unexpected Safety Issues of LBM415, a Novel Oral Peptide Deformylase InhibitorP Rolan, H Sun, C MacLeod, K Bracken and T G Evans Clin Pharmacol Ther 2011 90: 256-262; advance online publication, June 29, 2011; 10.1038/clpt.2011.101 Abstract | Full Text |
 |
 |
 |
Nonlinear Pharmacokinetics of Oral Quinidine and Verapamil in Healthy Subjects: A Clinical Microdosing Study K Maeda, J Takano, Y Ikeda, T Fujita, Y Oyama, K Nozawa, Y Kumagai and Y Sugiyama Clin Pharmacol Ther 2011 90: 263-270; advance online publication, June 29, 2011; 10.1038/clpt.2011.108 Abstract | Full Text |
 |
 |
 |
Can Network Analysis Improve Pattern Recognition Among Adverse Events Following Immunization Reported to VAERS? R Ball and T Botsis Clin Pharmacol Ther 2011 90: 271-278; advance online publication, June 15, 2011; 10.1038/clpt.2011.119 Abstract | Full Text |
 |
 |
 |
Profile of Serum Bile Acids in Noncholestatic Volunteers: Gender-Related Differences in Response to Fenofibrate J Trottier, P Caron, R J Straka and O Barbier Clin Pharmacol Ther 2011 90: 279-286; advance online publication, June 29, 2011; 10.1038/clpt.2011.124 Abstract | Full Text |
 |
 |
 |
Genetic Polymorphisms and the Impact of a Higher Clopidogrel Dose Regimen on Active Metabolite Exposure and Antiplatelet Response in Healthy Subjects T Simon, D L Bhatt, L Bergougnan, C Farenc, K Pearson, L Perrin, E Vicaut, F LaCreta, F Hurbin and M Dubar Clin Pharmacol Ther 2011 90: 287-295; advance online publication, June 29, 2011; 10.1038/clpt.2011.127 Abstract | Full Text |
 |
 |
 |
Exposure to Oral S-ketamine Is Unaffected by Itraconazole but Greatly Increased by TiclopidineM A Peltoniemi, T I Saari, N M Hagelberg, P Reponen, M Turpeinen, K Laine, P J Neuvonen and K T Olkkola Clin Pharmacol Ther 2011 90: 296-302; advance online publication, June 29, 2011; 10.1038/clpt.2011.140 Abstract | Full Text |
 |
Discovery & Development | Top |
 |
DISCOVERY
|
Pharmacology of Synergism Among Immunosuppressive Drugs for Transplantation B D Kahan Clin Pharmacol Ther 2011 90: 303-309; advance online publication, June 29, 2011; 10.1038/clpt.2011.100 Abstract | Full Text |
 |
 |
 |
New Therapeutic Approaches to Antibody-Mediated Rejection in Renal TransplantationS Raghavaiah and M D Stegall Clin Pharmacol Ther 2011 90: 310-315; advance online publication, July 6, 2011; 10.1038/clpt.2011.123 Abstract | Full Text |
 |
 |
 |
TRANSLATION
|
Biomarkers of Over-Immunosuppression K Budde, M Matz, M Dürr and P Glander Clin Pharmacol Ther 2011 90: 316-322; advance online publication, June 29, 2011; 10.1038/clpt.2011.111 Abstract | Full Text |
 |
 |
 |
Applications of Translational Bioinformatics in TransplantationP Khatri, M M Sarwal and A J Butte Clin Pharmacol Ther 2011 90: 323-327; advance online publication, June 29, 2011; 10.1038/clpt.2011.120 Abstract | Full Text |
 |
 |
 |
Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450-2C19 (CYP2C19) Genotype and Clopidogrel Therapy S A Scott, K Sangkuhl, E E Gardner, C M Stein, J-S Hulot, J A Johnson, D M Roden, T E Klein and A R Shuldiner Clin Pharmacol Ther 2011 90: 328-332; advance online publication, June 29, 2011; 10.1038/clpt.2011.132 Abstract | Full Text |
 |
Regulation & Use | Top |
 |
PRACTICE
|
Management of Infectious Complications in Solid-Organ Transplant Recipients S A Grim and N M Clark Clin Pharmacol Ther 2011 90: 333-342; advance online publication, June 29, 2011; 10.1038/clpt.2011.90 Abstract | Full Text |
 |
Corrigenda | Top |
 |
CORRIGENDUM
|
CORRIGENDUM: Pharmacologic Opportunities for HIV Prevention Clin Pharmacol Ther 2011 90: 343; 10.1038/clpt.2011.137 Abstract | Full Text |
 |
 |
 |
CORRIGENDUM: Abstract OIII-B-1: Genetic Markers Associated With Platinum/Taxanes-Induced Gastrointestinal Toxicity in SCOTROC1 Trial Clin Pharmacol Ther 2011 90: 344; 10.1038/clpt.2011.24 Abstract | Full Text |
 |
 |
 |
 |
 |
| Advertisement |
 |
Focus on: Transplant Pharmacology Challenges beyond the transplant. A quest for long term graft survival.
Hosted by: Clinical Pharmacology & Therapeutics
In conjunction with: - Kidney International - Nature Medicine - Nature Reviews Nephrology | |
 |
| |
Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Clinical Pharmacology & Therapeutics. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2011 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. |
 |
| |
No comments:
Post a Comment